ImpediMed Limited IPDQF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 17.12% | 16.92% | 26.00% | 22.15% | 17.95% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.12% | 16.92% | 26.00% | 22.15% | 17.95% |
| Cost of Revenue | -3.03% | -3.18% | 32.06% | 28.02% | 47.09% |
| Gross Profit | 20.77% | 20.57% | 25.19% | 21.36% | 13.86% |
| SG&A Expenses | 4.67% | 4.50% | 5.10% | 1.88% | 18.46% |
| Depreciation & Amortization | -0.78% | -0.95% | -3.75% | -6.69% | 110.40% |
| Other Operating Expenses | 56.74% | 56.46% | 6.52% | 3.27% | -67.39% |
| Total Operating Expenses | 6.72% | 6.55% | 5.28% | 2.06% | 8.71% |
| Operating Income | -0.62% | -0.45% | 5.48% | 8.37% | -3.93% |
| Income Before Tax | -15.76% | -15.57% | -10.97% | -7.58% | -16.70% |
| Income Tax Expenses | -10.42% | -10.64% | 27.78% | 24.32% | 11.63% |
| Earnings from Continuing Operations | -15.72% | -15.53% | -10.99% | -7.60% | -16.70% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -15.72% | -15.53% | -10.99% | -7.60% | -16.70% |
| EBIT | -0.62% | -0.45% | 5.48% | 8.37% | -3.93% |
| EBITDA | -1.13% | -0.45% | 5.89% | 8.76% | -4.18% |
| EPS Basic | -5.26% | -5.26% | -11.11% | -11.11% | -18.75% |
| Normalized Basic EPS | -8.33% | 0.00% | -9.09% | 0.00% | -20.00% |
| EPS Diluted | -5.26% | -5.26% | -11.11% | -11.11% | -18.75% |
| Normalized Diluted EPS | -8.33% | 0.00% | -9.09% | 0.00% | -20.00% |
| Average Basic Shares Outstanding | 10.88% | 10.88% | 0.53% | 0.53% | -0.40% |
| Average Diluted Shares Outstanding | 10.88% | 10.88% | 0.53% | 0.53% | -0.40% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |